Re: Threshold Pharmaceuticals, Inc (THLD): Opiniones
estamos juguetones
premarket 1.800 acciones y a 4,21$
estamos juguetones
premarket 1.800 acciones y a 4,21$
Threshold Pharmaceuticals Announces Its Phase 3 Trial of TH-302 in Patients With Advanced Soft Tissue Sarcoma Will Continue as Planned Following Protocol-Specified Interim Analysis
Published: Sept 22, 2014 8:02 a.m. ET
................... anda que va bien >>> Pre-market: 4.21 -0.26 (-5.82%)
No indican los resultados obtenidos... Únicamente hacen mención a los mínimos a cumplir. A ver si el breve sabemos más.
el estudio es CIEGO. los interim data se publican asi. no hay mas.
Pues vaya, no hay nada que rascar entonces. Seguiremos con el lateral de los últimos años.
yo entiendo que es un estudio "provisional",... quizás se pronuncien en unos dias no ??
Threshold and its partner Merck KGaA, Darmstadt, Germany, have been and will remain blinded to the data from the trial. Based on projections derived from the interim analysis, Threshold is revising its guidance on timing for the number of events (deaths) required for the primary efficacy analysis. Previously, the Company projected the pre-specified number of events (n=434) would occur around the middle of 2015; the revised projections suggest the requisite events will occur in the latter half of 2015.
Acordaros de los 26 millones de acciones (no recuerdo la cifra exacta) de volumen en el mvto de la semana pasada.
El premarket de ahora tiene el espectacular volumen de ... 16.000 acciones